Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556902 · ClinicalTrials.gov registry record · NA

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

A NA study of Hypertension and Low Back Pain, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05556902 is a NA study of Hypertension and Low Back Pain that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556902, a NA study of Hypertension and Low Back Pain, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS, and finally 3) whether different SCS waveforms elicits stimulus-evoked compound action potentials (ECAPs) in spinal cord and at the cortex (electroencephalography, and magnetoenchphalography).

Interventions

  • DEVICE Permanent Epidural Spinal Cord Stimulation

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-08-02
Est. Completion 2030-05-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05556902

The ClinicalTrials.gov registry entry for NCT05556902 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Permanent Epidural Spinal Cord Stimulation is the first listed.

NCT05556902 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05556902 about?

NCT05556902 is a clinical study titled "Therapeutic Mechanisms of Epidural Spinal Cord Stimulation". The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in...

What is the current status of trial NCT05556902?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-08-02. Estimated completion is 2030-05-01.

What conditions does trial NCT05556902 study?

This clinical trial studies the following conditions: Hypertension, Low Back Pain, Blood Pressure.

What interventions are being tested in trial NCT05556902?

The interventions under investigation include: Permanent Epidural Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05556902?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05556902 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.